On Demand 2019 ACAAI ASM Thursday Program
The Thursday Program contains the morning and afternoon sessions:
Food Allergy Prevention
Harmonization, Differences in Guidelines, Unmet Needs and Implementation Barriers
The Microbiome and Exposome: A Saucer Full of Secrets
The Role of Diet Diversity and Other Factors Beyond Early Introduction in Promoting Prevention
- Rectifying Direct and Indirect Methods of Assessing Prevalence: Where We Are, Why Rates Differ and the Importance of Population-level Studies
- Birth and Infant Cohorts: Why These Are Needed – the International Perspective
- Food Allergy in Africa: the SAFAR Cohort
From the Horse’s Mouth – The FDA Perspective on Treatment and Unmet Needs
Food Allergy Treatment
- Treatment Updates: What are our Present Options
- New Horizons: Anticipating the Next Evolution in Treatments
- Shared Decision-making and Understanding Parental Preference in Choice of Food Allergy Treatment
Bigger Success Begets Bigger Problems: Issues on the Horizon
- Cost-effective Practices in Food Allergy and Anaphylaxis
- Something Borrowed, Something Blue, Something Old, Something New: Making Sense of Older Versus New Diagnostic and Lab Technologies for Treatment Monitoring
- Social Media, Advocacy and the Rise of Myths and Alternative Facts in Food Allergy
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Detail the discrepancies between different international food allergy prevention guidelines and highlight where better harmonization could be promoted.
- Discuss the current understanding of how the microbiome and exposome may contribute to the development and prevention of food allergies.
- Describe the concept of diet diversity and highlight the importance of diet diversity as a tool in food allergy prevention.
- Understand how the effects of methodology differences in measuring food allergy can affect food allergy prevalence estimates.
- Identify the value of the longitudinal birth cohort in tracking the trajectory of food allergy and other allergic diseases as a child develops from infancy to youth.
- Describe the differences in a rural versus urban population cohort in terms of the development of food allergy.
- Assist patients in understanding food allergen precautionary labeling requirements and limitations.
- Describe the relative arguments regarding the future commercialization of food immunotherapy
- Identify key differences between epicutaneous and oral immunotherapy as options for treating peanut allergy
- Detail key arguments regarding the necessity of a diagnostic food challenge prior to starting food immunotherapy
- Discuss currently-available treatment options for food immunotherapy.
- Detail the robust clinical pipeline and next generation of research regarding future potential treatment options.
- Understand how to utilize shared decision-making when discussing treatment options with parents and patients.
- Detail the cost-effectiveness of diagnostic and management strategies within food allergy.
- Understand the current limitations of diagnostic testing for food allergy and describe potential future options under development.
- Address misinformation regarding food allergy found online and through non-reputable resources and describe how to handle being presented with this by parents and patients during clinical encounters.
Syed H. Arshad, MBBS, DM
Warner W. Carr, MD, FACAAI
Matthew Greenhawt, MD, MSc, MBA, FACAAI
Jonathan Hourihane, MD
Edwin H. Kim, MD, FACAAI
Michael Levin, MD, PhD, FACAAI
Stefano Luccioli, MD
Rachel Peters, MPH, PhD
Susan Prescott, MD, PhD
Rima A. Rachid, MD
Marcus Shaker, MD, MSc, FACAAI
Wayne G. Shreffler, MD, PhD
David R. Stukus, MD, FACAAI
Carina Venter, PhD, RD
- 7.25 AMA PRA Category 1 Credit™
- 7.25 Attendance
- 7.25 CBRN